A study in the UK demonstrated significant improvements in HbA1c for users of automated insulin delivery technologies. This comes on the heels of a UK NHS initiative to provide tens of thousands of children and adults with type 1 diabetes in the … [Read More...] about Study highlights benefits of automated insulin delivery for children in UK
Main Content
Drug Tech
Today on Drug Delivery Business
- Medtronic MiniMed 780G recognized as a ‘World-Changing Idea’
- Dexcom launches new sensor in the UK
- FDA warns on more Chinese syringe imports
- Enable Injections inks deal to develop Parkinson’s therapy for delivery with EnFuse
- Carthera wins U.S., EU orphan drug designation for SonoCloud
- Medtronic, Arecor team up to develop insulin for implantable pumps
- Senseonics posts Q1 sales beat, submits 365-day iCGM to FDA
Sponsored Content
Introduce New Drug Delivery Medical Devices with Lower Risk and Higher ROI
Manufacturing automation is crucial to achieving the precision, quality, and volume required in the medical device industry. Advanced robotics, AI, modular designs, and wireless technology offer the … [Read More...] about Introduce New Drug Delivery Medical Devices with Lower Risk and Higher ROI
Featured Posts
Medtronic MiniMed 780G recognized as a ‘World-Changing Idea’
By Sean Whooley
Fast Company has named the Medtronic (NYSE:MDT) MiniMed 780G automated insulin delivery system among the "Best World-Changing Ideas" of 2024. The next-generation MiniMed 780G system won FDA approval just over a year ago. It uses the latest … [Read More...] about Medtronic MiniMed 780G recognized as a ‘World-Changing Idea’
Dexcom launches new sensor in the UK
By Sean Whooley
Dexcom (Nasdaq:DXCM) announced today that it launched the Dexcom ONE+ continuous glucose monitor (CGM) in the UK. ONE+ uses Dexcom’s established sensor design, with the company incorporating feedback from users and healthcare professionals to … [Read More...] about Dexcom launches new sensor in the UK
FDA warns on more Chinese syringe imports
By Sean Whooley
The FDA added two new China-based companies to its list of syringe manufacturers that can no longer import products to the U.S. In an alert dated May 16, the FDA said Zhejiang Longde Pharmaceutical Co. and Shanghai Kindly Enterprise Development … [Read More...] about FDA warns on more Chinese syringe imports
Enable Injections inks deal to develop Parkinson’s therapy for delivery with EnFuse
By Sean Whooley
Enable Injections announced today that it partnered with Serina Therapeutics to develop therapeutics for the enFuse delivery system. The companies aim to develop and commercialize SER-252 (POZ-apomorphine) in combination with enFuse to treat … [Read More...] about Enable Injections inks deal to develop Parkinson’s therapy for delivery with EnFuse
Carthera wins U.S., EU orphan drug designation for SonoCloud
By Sean Whooley
Carthera announced today that it received FDA and European orphan drug designation (ODD) for the use of carboplatin with its SonoCloud. The designation allows Paris, France-based Carthera to use carboplatin chemotherapy in the treatment of … [Read More...] about Carthera wins U.S., EU orphan drug designation for SonoCloud
Medtronic, Arecor team up to develop insulin for implantable pumps
By Sean Whooley
Arecor and Medtronic say they partnered to create a new type of insulin that would allow for the use of new insulin pump designs. These new insulin pumps in mind would sit under the skin, rather than on the surface of the skin. The research … [Read More...] about Medtronic, Arecor team up to develop insulin for implantable pumps
Senseonics posts Q1 sales beat, submits 365-day iCGM to FDA
By Sean Whooley
Senseonics (NYSE:SENS) shares ticked up after the market closed today on first-quarter results that came in ahead of the consensus sales forecast. Shares of SENS rose 8.1% to 41¢ apiece in post-market trading today. MassDevice’s MedTech 100 Index — … [Read More...] about Senseonics posts Q1 sales beat, submits 365-day iCGM to FDA
Senseonics, Rimidi partner on remote diabetes monitoring program
By Sean Whooley
Senseonics (NYSE:SENS) announced today that it entered into a strategic partnership with Rimidi to develop a remote patient monitoring program. Rimidi develops clinical management platforms for optimizing workflows, enhance patient experiences and … [Read More...] about Senseonics, Rimidi partner on remote diabetes monitoring program
Insulet sales are up 23% but Q1 EPS misses Wall Street forecast
By Sean Whooley
Insulet (Nasdaq:PODD) shares fell after hours today on first-quarter results that came in mixed compared to the consensus forecast. Shares of PODD dipped 3% to $172 apiece in after the market closed today. The Acton, Massachusetts-based automated … [Read More...] about Insulet sales are up 23% but Q1 EPS misses Wall Street forecast
Recall of Tandem Diabetes Care insulin pump app software is Class I, more than 200 injuries reported
By Sean Whooley
The FDA labeled a recall of a Tandem Diabetes Care (Nasdaq:TNDM) automated insulin delivery app's software Class I, the most serious kind. This recall constitutes a correction, not a product removal. Tandem recalled Version 2.7 of the Apple iOS … [Read More...] about Recall of Tandem Diabetes Care insulin pump app software is Class I, more than 200 injuries reported
In case you missed it
- Embecta stock skyrockets on Q1 beats, increased guidance as insulin pump tech progresses
- Medtronic warns on MiniMed 780G battery caps in Europe
- Insulet Omnipod 5 picks up reimbursement in France
- Enable Injections, Roche expand enFuse delivery partnership
- Xeris, Beta Bionics collab on glucagon product for pumps
- Tandem stock skyrockets on Q1 sales beat, increased pump shipments
- Senseonics wins integrated CGM designation from FDA, can work with insulin pumps
- Abbott wins FDA approval for dissolving drug-eluting scaffold
- Report: Abbott files trio of patent lawsuits over CGM tech in Europe
- Dexcom stock slides despite Q1 beats, sales guidance increase
- FDA says InfuTronix infusion pump recall includes 1 death
- ICU Medical’s Smiths Medical is reportedly closing a New Hampshire plant, cutting 220 jobs
- Study highlights benefits of automated insulin delivery for children in UK
- Non-insulin, basal CGM use exceeds analysts’ expectations, Dexcom and Abbott to benefit
- Concept Medical enrolls first patient in drug-coated balloon study
Clinical Trials
Study highlights benefits of automated insulin delivery for children in UK
A study in the UK demonstrated significant improvements in HbA1c for users of automated insulin delivery technologies. This comes on the heels of a UK NHS initiative to provide tens of thousands of children and adults with type 1 diabetes in the country with an artificial pancreas. The study aimed to assess the efficacy of […]
Concept Medical enrolls first patient in drug-coated balloon study
Concept Medical announced today that it commenced the FDA investigational device exemption (IDE) study of its MagicTouch system. MagicTouch, a sirolimus drug-coated balloon (DCB), treats in-stent restenosis (ISR) in coronary artery disease (CAD). Dr. Said Ashraf enrolled the first patient in the MAGICAL-ISR study at the AtlantiCare Institute in Atlantic City, New Jersey. The balloon […]
Glucotrack expands CGM tech to spinal epidural space
Glucotrack (Nasdaq:GCTK) announced today that it plans to expand its glucose monitoring technology to measure glucose in the epidural space. Rutherford, New Jersey-based Glucotrack said CGM taking readings in the spinal epidural space could integrate with existing treatments for painful diabetic neuropathy (PDN). Specifically, Glucotrack sees spinal cord stimulation (SCS) technology as a potential integration […]
OM1, Medtronic partner on drug-eluting implant study
OM1 today announced positive results from its partnership with Medtronic (NYSE:MDT) evaluating the Propel corticosteroid-eluting implants. The Propel bioabsorbable implant family came to Medtronic through its acquisition of IntersectENT in 2022. OM1 and Medtronic partnered on their study to focus on healthcare resource use and long-term outcomes in patients with chronic rhinosinusitis (CRS) who underwent […]
The biggest diabetes tech news out of ATTD 2024
Catch up on the latest in diabetes tech from Dexcom, Abbott, Roche Diabetes Care, Insulet, Medtronic and Know Labs. Every year, the diabetes community comes together for the International Conference on Advanced Technologies & Treatments for Diabetes (ATTD). In this year’s 17th installment, some of the biggest names shared new studies and technologies set to […]